Equities Mid-Day Stock Market Roundup: Osama Bin Laden is Dead.

Equities Editors Desk |

Barack Obama Osama Bin Laden DeathWall Street gave back all their early trading gains today--and then some--as news of the death of Al Qaeda leader Osama Bin Laden apparently only had a short-term positive effect on the stock market. Though Bin Laden is now dead, experts still believe that Al Qaeda is an ongoing concern. Economists do not believe that the death of Bin Laden will have significant impact Oil prices also dipped in early morning trading, but have since recovered losses. Crude delivery for June is now trading above $114 per barrel. U.S. Treasuries have seesawed as well. New economic data showed that construction spending recovered last month but the pace of U.S. manufacturing growth has slowed for a second consecutive month in April. Gold prices are also up, trading at around $1560 per ounce.

Major U.S. Indices

DJIA: 12,829.01 (+0.14 percent)
S&P 500: 1,364.69 (+0.08 percent)
Nasdaq: 2,872.94 (-0.02 percent)
Russell 2000: 858.54 (-0.78 percent)

In other news:

  • More on the killing of Osama Bin Laden and the impact of his death. [Economist]
  • How to trade Osama Bin Laden. [The Street]
  • Can we get a slow clap for Chrysler? [WSJ]
  • Teva Pharmaceuticals (NASDAQ: TEVA), the world's largest generic drugmaker, is buying biopharmaceutical company Cephalon (NASDAQ: CEPH) for $6.8 billion, or $81.50 a share. That represents a 39 percent premium on the share price before the news. [NY Times]
  • World Wrestling Entertainment (NYSE: WWE) shares got hammered after the company announced the highly expected dividend cut on Friday. Shares are recovering in Monday trading though. [AP]

Check back for more news.


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
IOT Income Opportunity Realty Investors Inc. 7.26 -0.47 -6.12 100


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…